Español
India
Italiano
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cardiol Therapeutics
CRDL
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$2.02
0.02
1.00%
At Close: -
$1.99
-0.03
-1.49%
After Hours: 6:54 PM EDT
15 minutes delayed
Get Report
Watch
Cardiol Therapeutics (CRDL) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cardiol Therapeutics (NASDAQ:CRDL) Stock
Cardiol Therapeutics Stock (NASDAQ: CRDL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 26, 2024
Roth MKM Initiates Coverage On Cardiol Therap...
Benzinga Newsdesk
Friday, June 14, 2024
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Thursday, June 13, 2024
Cardiol Therapeutics shares are trading lower...
Benzinga Newsdesk
Cardiol Therapeutics Presented Topline Data F...
Benzinga Newsdesk
Friday, June 07, 2024
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Thursday, May 23, 2024
Canaccord Genuity Maintains Buy on Cardiol Th...
Benzinga Newsdesk
Tuesday, May 14, 2024
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Nicolás Jose Rodriguez
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Monday, April 22, 2024
HC Wainwright & Co. Initiates Coverage On Car...
Benzinga Newsdesk
Tuesday, April 02, 2024
Cardiol Therapeutics Q4 EPS $(0.09) Beats $(0...
Benzinga Newsdesk
Cardiol Therapeutics' Cash And Cash Equivalen...
Benzinga Newsdesk
Thursday, February 15, 2024
Cardiol Therapeutics shares are trading highe...
Benzinga Newsdesk
Cardiol Therapeutics Says FDA Granted Orphan ...
Benzinga Newsdesk
Tuesday, January 09, 2024
Cardiol Therapeutics Exceeds 50% Enrollment I...
Benzinga Newsdesk
Thursday, October 12, 2023
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations
Beau Sharpe
Tuesday, October 10, 2023
CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects
Jelena Martinovic
Thursday, September 21, 2023
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, September 19, 2023
Cardiol Therapeutics Announces All Collaborat...
Benzinga Newsdesk
Monday, August 14, 2023
Cantor Fitzgerald Reiterates Overweight on Ca...
Benzinga Newsdesk
Friday, May 19, 2023
Canaccord Genuity Maintains Buy on Cardiol Th...
Benzinga Newsdesk
Tuesday, January 17, 2023
Reported Earlier, Cardiol Therapeutics Says F...
Benzinga Newsdesk
Monday, November 14, 2022
Cardiol Therapeutics Receives Nasdaq Deficien...
Benzinga Newsdesk
Friday, October 21, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, October 19, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, October 18, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Tuesday, October 11, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 10, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, October 07, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, October 04, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 03, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Cardiol Therapeutics Announces Pre-Clinical S...
Benzinga Newsdesk
Thursday, June 09, 2022
Cardiol Therapeutics Announces At-The-Market ...
Benzinga Newsdesk
Thursday, May 19, 2022
76 Biggest Movers From Yesterday
Lisa Levin
Tuesday, May 17, 2022
FDA Clears Cardiol Therapeutics' IND for CardiolRx in Recurrent Pericarditis
Ragothaman Srinivasan
Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization For Multicenter Phase II Open-Label Pilot Study Of CardiolRx For Recurrent Pericarditis
Bill Haddad
Tuesday, April 19, 2022
68 Biggest Movers From Yesterday
Lisa Levin
Monday, April 18, 2022
34 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
51 Biggest Movers From Thursday
Lisa Levin
Thursday, March 17, 2022
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022
Benzinga Insights
Friday, March 11, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, March 01, 2022
Cardiol Therapeutics To Include Vaccinated Participants In Cannabidiol COVID-19 Trial
Vandana Singh
Cardiol Therapeutics Receives Clearance From ...
Bill Haddad
Tuesday, February 22, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, January 20, 2022
52 Biggest Movers From Yesterday
Lisa Levin
Wednesday, January 19, 2022
65 Biggest Movers From Yesterday
Lisa Levin
Tuesday, January 18, 2022
52 Biggest Movers From Friday
Lisa Levin
Thursday, January 06, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, December 17, 2021
Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021
Benzinga Insights
Cantor Fitzgerald Initiates Coverage On Cardi...
Benzinga Newsdesk
Friday, December 03, 2021
Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021
Benzinga Insights
Show More